| __timestamp | Alnylam Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 19586000 |
| Thursday, January 1, 2015 | 276495000 | 29135000 |
| Friday, January 1, 2016 | 382392000 | 42791000 |
| Sunday, January 1, 2017 | 390635000 | 49577000 |
| Monday, January 1, 2018 | 505420000 | 89209000 |
| Tuesday, January 1, 2019 | 655114000 | 69099000 |
| Wednesday, January 1, 2020 | 654819000 | 75961000 |
| Friday, January 1, 2021 | 792156000 | 90467000 |
| Saturday, January 1, 2022 | 883015000 | 74552000 |
| Sunday, January 1, 2023 | 1004415000 | 91593000 |
| Monday, January 1, 2024 | 1126232000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Since 2014, Alnylam has consistently increased its R&D expenses, culminating in a 428% rise by 2023. This upward trend underscores Alnylam's dedication to pioneering new treatments and maintaining its competitive edge in the biotech industry.
In contrast, Supernus has shown a more modest growth in R&D spending, with a 368% increase over the same period. While their investment is smaller in absolute terms, it reflects a strategic focus on targeted innovation.
This comparison highlights the diverse strategies within the pharmaceutical sector, where both aggressive and measured R&D investments can drive success.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Genmab A/S
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.